Individuals Coming Off Weight-Loss Jabs Gain Back Pounds Far More Rapidly Compared to Those on Conventional Diets

New research suggests that individuals who come off new slimming jabs like Mounjaro or Wegovy tend to recover lost weight at a significantly accelerated pace than those who stop traditional diet and exercise plans.

Research printed in a leading health publication demonstrates that while overweight people frequently drop a large proportion of their body weight while undergoing treatment, the weight comes back at an estimated rate of 0.8 kg per month after stopping.

"Individuals using these treatments need to be aware of the potential of quick weight regain when the treatment is stopped," stated researcher Dr. Susan Jebb.

This pace of recovery implies a return to pre-treatment mass in about a year and a half.

Analyzing Approaches

The study, which examined 37 of trials involving over 9,000 of patients, compared the outcomes of these new drugs with other pills.

Scientists point out that people who shed pounds through diet and exercise usually have a less rapid creep back—perhaps 100 grams monthly—post-intervention.

The Reason for the Fast Regain

Nutrition scientists propose the way of the jabs explains the heightened rebound.

GLP-1 drugs copy a natural hormone called glucagon-like peptide-1, which helps regulate feelings of fullness.

"Long-term administration of GLP-1 concentrations far above than the body's typical production may cause the system to generate a reduced amount of its own natural hormone, and may also diminish sensitivity to its effects," said Dr. Adam Collins, a dietetics expert.

"Withdrawal of this GLP-1 'fix' results in hunger is uncontrolled, making overeating much more probable."

A Lifelong Issue?

Medical guidelines suggest the jabs for individuals with obesity-related health risks, accompanied by prescribed lifestyle changes.

Professionals say that, given the significant potential of weight regain, the therapy is often life-long.

This perspective is supported by pharmaceutical companies, who say that the results "highlight the long-term nature of excess weight," akin to managing conditions like hypertension.

User Accounts

Individuals who have discontinued the medication report a intense return of cravings.

"I experienced something that goes on and you become starving," said one woman.

The struggle is exacerbated if users have not developed permanent dietary or behavioural modifications during therapy.

Growing Adoption

Recent estimates suggest that millions of people in the UK have tried weight-loss jabs in the past year, with interest being substantial.

• Use is more common among women than men.
• The middle-aged age group shows the highest level of interest.
• A large proportion obtain the drugs through private healthcare rather than the NHS.

Finally, clinicians caution that while the jabs are effective agents for weight loss, they are not a magic solution and maintained weight loss hinges on ongoing behavioural management.